『Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease』のカバーアート

Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease

Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease

無料で聴く

ポッドキャストの詳細を見る

Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substantial underestimation and potential reclassification from MASLD to MetALD/ALD.

Click here to read the full article:

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00187-6/fulltext

Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics.

You can visit https://www.thelancet.com/medical-imaging-theranostics to learn more.

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv

The Lancet Gastroenterology & Hepatology in conversation with... is part of the Lancet Group podcast offering.

Editorial team: editor-in-chief Rob Brierley, deputy editor Aisling O'Brien, and senior editor Bethany Gomersall

Podcast editing: Matteo Simonetti

Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.

Find the best science for better lives at https://www.thelancet.com/ Follow us today at... x.com/LancetGastroHep bsky.app/lancetgastrohep.bsky.social Linkedin.com Instagram Facebook youtube.com/thelancettv

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません